Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

28
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
28
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

26
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

20
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
20
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

19
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19
Goiter01:27

Goiter

29
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
29
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

20
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolution and Validation of Thyroid Cancer Guidelines as Evidence Advances Toward Individualized Therapy.

The Journal of clinical endocrinology and metabolism·2026
Same author

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Sense of Belonging from Celebrated Identity: Getting to Know Interns Through Surgical Grand Rounds.

Journal of surgical education·2026
Same author

Implications of Changing Institutions for Promotion in Academic Surgery.

JAMA surgery·2025
Same author

Parenting in Surgery: A Structured Initiative to Support Surgeons Navigating Pregnancy and Early Parenthood During Training.

Journal of surgical education·2025
Same author

Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.

JCO oncology practice·2025

Related Experiment Video

Updated: Apr 27, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.3K

Prophylactic thyroidectomy: who needs it, when, and why.

Tracy S Wang1, Adwoa Opoku-Boateng, Sanziana A Roman

  • 1Medical College of Wisconsin, Milwaukee, Wisconsin.

Journal of Surgical Oncology
|June 27, 2014
PubMed
Summary
This summary is machine-generated.

Prophylactic thyroidectomy is recommended for hereditary medullary thyroid cancer. Surgery timing and extent, including neck dissection, depend on specific RET mutations and metastatic risk, ideally performed at specialized centers.

Keywords:
MEN 2AMEN 2Bfamilial MTCmedullary thyroid cancerprophylactic thyroidectomy

More Related Videos

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

829
Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

943

Related Experiment Videos

Last Updated: Apr 27, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1.3K
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

829
Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy
05:25

Identification and Protection of the Recurrent Laryngeal Nerve during Transoral Robotic Thyroidectomy

Published on: October 24, 2025

943

Area of Science:

  • Endocrinology
  • Surgical Oncology
  • Genetics

Background:

  • Medullary thyroid cancer (MTC) is the most common hereditary thyroid cancer.
  • It is associated with Multiple Endocrine Neoplasia types 2A and 2B (MEN 2A, MEN 2B), and Familial Medullary Thyroid Cancer (FMTC).
  • RET proto-oncogene mutations are key drivers in these hereditary syndromes.

Purpose of the Study:

  • To outline the current recommendations for prophylactic thyroidectomy in hereditary medullary thyroid cancer.
  • To emphasize the importance of individualized surgical timing and extent based on genetic factors.
  • To highlight the necessity of specialized surgical care for optimal patient outcomes.

Main Methods:

  • Review of current clinical guidelines and literature on hereditary medullary thyroid cancer management.
  • Analysis of the role of RET mutation status in surgical decision-making.
  • Emphasis on risk stratification for central compartment neck dissection.

Main Results:

  • Prophylactic thyroidectomy is the standard of care for individuals with hereditary MTC syndromes.
  • The specific RET mutation dictates the optimal timing for prophylactic surgery.
  • Total thyroidectomy is recommended, with central compartment neck dissection reserved for high-risk patients with potential micro-metastatic disease.

Conclusions:

  • Management of hereditary medullary thyroid cancer requires a multidisciplinary approach.
  • Personalized surgical strategies based on RET mutation analysis are crucial.
  • High-volume, specialized endocrine surgery centers provide the best outcomes for these complex cases.